MSC-Derived Extracellular Vesicle-Delivered L-PGDS Inhibit Gastric Cancer Progression by Suppressing Cancer Cell Stemness and STAT3 Phosphorylation

<div>Identification and differentiation potential of huc-MSCs. (a) MSCs with their characteristic fusiform shape were grown on the 10th day of culture (×40). (b) Oil Red O staining for the adipogenic differentiation of huc-MSCs (×100). (c) Alizarin Red staining for the osteogenic differentiation of huc-MSCs (×100). (d) Flow cytometry for the surface antigens of huc-MSCs. The huc-MSCs expressed CD105, CD29, and CD73 but lacked expression of CD11b, CD34, and CD45.</div>

Stem Cells International

fig1

Figure 1

Figure 1: MSC-Derived Extracellular Vesicle-Delivered L-PGDS Inhibit Gastric Cancer Progression by Suppressing Cancer Cell Stemness and STAT3 Phosphorylation 

Figure 1 | MSC-Derived Extracellular Vesicle-Delivered L-PGDS Inhibit Gastric Cancer Progression by Suppressing Cancer Cell Stemness and STAT3 Phosphorylation 